HUM vs NXTC · P/E 39, rev $129.66B vs $11.5M cap
Humana Inc (HUM) versus NextCure Inc (NXTC) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
NextCure Inc (NXTC) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
NXTC does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. NXTC currently screens at market cap $11.5M.
Not investment advice. Open the HUM and NXTC stock pages for the full models.
Not investment advice.